20-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment

被引:19
|
作者
Margolin, Leon [1 ]
Luchins, Jeremy [1 ]
Margolin, Daniel [1 ]
Margolin, Michelle [1 ]
Lefkowitz, Sanford [1 ]
机构
[1] Comprehens Pain Management Inst LLC, 5245 E Main St, Columbus, OH 43213 USA
关键词
COVID-19; SARS-CoV-2; prophylaxis; early-stage treatment; OTC; zinc; ionophores; immunity enhancement; regimen compliance; ZINC; QUERCETIN; RISK; TRANSMISSION; CORONAVIRUS; SUPPRESSION; INHIBITION; QUININE;
D O I
10.1177/2515690X211026193
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objectives and Setting. As the lethal COVID-19 pandemic enters its second year, the need for effective modalities of alleviation remains urgent. This includes modalities that can readily be used by the public to reduce disease spread and severity. Such preventive measures and early-stage treatments may temper the immediacy of demand for advanced anti-COVID measures (drugs, antibodies, vaccines) and help relieve strain also on other health system resources. Design and Participants. We present results of a clinical study with a multi-component OTC "core formulation" regimen used in a multiply exposed adult population. Analysis of clinical outcome data from our sample of over 100 subjects - comprised of roughly equal sized regimen-compliant (test) and non-compliant (control) groups meeting equivalent inclusion criteria - demonstrates a strong statistical significance in favor of use of the core formulations. Results. While both groups were moderate in size, the difference between them in outcomes over the 20-week study period was large and stark: Just under 4% of the compliant test group presented flu-like symptoms, but none of the test group was COVID-positive; whereas 20% of the non-compliant control group presented flu-like symptoms, three-quarters of whom (15% overall of the control group) were COVID-positive. Conclusions. Offering a low cost, readily implemented anti-viral approach, the study regimen may serve, at the least, as a stopgap modality and, perhaps, as a useful tool in combatting the pandemic.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] The Abuse and Misuse of Over-the-Counter Medicines During COVID-19
    Al Meslamani, Ahmad Z.
    Abdel-Qader, Derar H.
    HOSPITAL PHARMACY, 2023, 58 (05) : 437 - 440
  • [2] FDA Approves First Over-the-counter Combined COVID-19 and Flu Test
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (12): : 968
  • [3] Guidance for Healthcare Providers on Newest Guidelines for Over-the-Counter Drug Treatment of Mild Symptoms of COVID-19
    Collamore, Gage
    Dicorcia, Mark J.
    Nagpal, Yash
    Fiedler, Lawrence
    Garone, Michael A.
    DeMets, David L.
    Maki, Dennis G.
    Hennekens, Charles H.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (06): : 490 - 493
  • [4] Internet Search Interest for Over-the-Counter Analgesics During the COVID-19 Pandemic
    Do, Thien Phu
    Do, Hien Quoc
    PAIN MEDICINE, 2021, 22 (10) : 2407 - 2408
  • [5] Health literacy characteristics of over-the-counter rapid antigen COVID-19 test materials
    Fulmer, Amy A.
    Abboud II, George A.
    Wallace, Lorraine S.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (12): : 4124 - 4128
  • [6] OVER-THE-COUNTER COVID-19 TESTS MAKE BIG PROMISES. DO THEY DELIVER?
    Satyanarayana, Megha
    Leeson, Kim
    CHEMICAL & ENGINEERING NEWS, 2021, 99 (20) : 28 - 35
  • [7] Internet Searches for Over-the-Counter Analgesics During the COVID-19 Pandemic Outbreak in Italy
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    PAIN MEDICINE, 2021, 22 (08) : 1885 - 1886
  • [8] Monitoring of over-the-counter (OTC) and COVID-19 treatment drugs complement wastewater surveillance of SARS-CoV-2
    Lee, Cheng-Shiuan
    Wang, Mian
    Nanjappa, Deepak
    Lu, Yi-Ta
    Meliker, Jaymie
    Clouston, Sean
    Gobler, Christopher J.
    Venkatesan, Arjun K.
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2024, 34 (03) : 448 - 456
  • [9] Over-the-counter Medication Use during Pandemic: Lessons Learned from Covid-19 in Lithuania
    Bikniute, I.
    Paric, M.
    Clemens, T.
    Commers, M.
    Brand, H.
    Vladickienea, J.
    Elands, R. J. J.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32 : III446 - III446
  • [10] Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic
    Karlsson, Par
    Nakitanda, Aya Olivia
    Lofling, Lukas
    Cesta, Carolyn E.
    PLOS ONE, 2021, 16 (08):